Foghorn Therapeutics Inc
NASDAQ:FHTX 4:00:00 PM EDT
Earnings Announcements
Foghorn Therapeutics Reports Q4 Loss Per Share $3.12
Published: 12/04/2020 13:08 GMT
Foghorn Therapeutics Inc (FHTX) - Foghorn Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update.
Q3 Loss per Share $3.12.
Q3 Earnings per Share Estimate $-1.72 -- Refinitiv Ibes Data (analyst estimates).
Cash and Cash Equivalents As of September 30, 2020 Were $74.6 Million.
Q3 Loss per Share $3.12.
Q3 Earnings per Share Estimate $-1.72 -- Refinitiv Ibes Data (analyst estimates).
Cash and Cash Equivalents As of September 30, 2020 Were $74.6 Million.
Revenue is expected to be $4.55 Million
Adjusted EPS is expected to be -$0.73
Next Quarter Revenue Guidance is expected to be $6.3 Million
Next Quarter EPS Guidance is expected to be -$0.68
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.73
Next Quarter Revenue Guidance is expected to be $6.3 Million
Next Quarter EPS Guidance is expected to be -$0.68
More details on our Analysts Page.